Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Safety and tolerability of nintedanib for the treatment of idiopathic pulmonary fibrosis in routine UK clinical practice.

Fletcher SV, Jones MG, Renzoni EA, Parfrey H, Hoyles RK, Spinks K, Kokosi M, Kwok A, Warburton C, Titmuss V, Thillai M, Simler N, Maher TM, Brereton CJ, Chua F, Wells AU, Richeldi L, Spencer LG.

ERJ Open Res. 2018 Oct 19;4(4). pii: 00049-2018. doi: 10.1183/23120541.00049-2018. eCollection 2018 Oct.

2.

Use of zonal distribution of lung crackles during inspiration and expiration to assess disease severity in idiopathic pulmonary fibrosis.

Key AL, Holt K, Warburton CJ, Walker PP, Earis JE.

Postgrad Med J. 2018 Jul;94(1113):381-385. doi: 10.1136/postgradmedj-2017-135320. Epub 2018 Jun 12.

PMID:
29895659
3.

In Vivo Validation of PAPSS1 (3'-phosphoadenosine 5'-phosphosulfate synthase 1) as a Cisplatin-sensitizing Therapeutic Target.

Leung AWY, Veinotte CJ, Melong N, Oh MH, Chen K, Enfield KSS, Backstrom I, Warburton C, Yapp D, Berman JN, Bally MB, Lockwood WW.

Clin Cancer Res. 2017 Nov 1;23(21):6555-6566. doi: 10.1158/1078-0432.CCR-17-0700. Epub 2017 Aug 8.

4.

Osteoclasts Are Required for Hematopoietic Stem and Progenitor Cell Mobilization but Not for Stress Erythropoiesis in Plasmodium chabaudi adami Murine Malaria.

Roméro H, Warburton C, Sanchez-Dardon J, Scorza T.

Mediators Inflamm. 2016;2016:3909614. doi: 10.1155/2016/3909614. Epub 2016 Jan 21.

5.

3'-Phosphoadenosine 5'-phosphosulfate synthase 1 (PAPSS1) knockdown sensitizes non-small cell lung cancer cells to DNA damaging agents.

Leung AW, Dragowska WH, Ricaurte D, Kwok B, Mathew V, Roosendaal J, Ahluwalia A, Warburton C, Laskin JJ, Stirling PC, Qadir MA, Bally MB.

Oncotarget. 2015 Jul 10;6(19):17161-77.

6.

Evaluating adaptive co-management as conservation conflict resolution: Learning from seals and salmon.

Butler JR, Young JC, McMyn IA, Leyshon B, Graham IM, Walker I, Baxter JM, Dodd J, Warburton C.

J Environ Manage. 2015 Sep 1;160:212-25. doi: 10.1016/j.jenvman.2015.06.019. Epub 2015 Jul 2.

7.

2013 November military issue.

Warburton C.

J Emerg Nurs. 2014 May;40(3):210-1. doi: 10.1016/j.jen.2014.02.002. Epub 2014 Mar 31. No abstract available.

PMID:
24698392
8.

Induction of autophagy is an early response to gefitinib and a potential therapeutic target in breast cancer.

Dragowska WH, Weppler SA, Wang JC, Wong LY, Kapanen AI, Rawji JS, Warburton C, Qadir MA, Donohue E, Roberge M, Gorski SM, Gelmon KA, Bally MB.

PLoS One. 2013 Oct 11;8(10):e76503. doi: 10.1371/journal.pone.0076503. eCollection 2013.

9.

Combined RNAi-mediated suppression of Rictor and EGFR resulted in complete tumor regression in an orthotopic glioblastoma tumor model.

Verreault M, Weppler SA, Stegeman A, Warburton C, Strutt D, Masin D, Bally MB.

PLoS One. 2013;8(3):e59597. doi: 10.1371/journal.pone.0059597. Epub 2013 Mar 15.

10.

COPD causation and workplace exposures: an assessment of agreement among expert clinical raters.

Fishwick D, Darby A, Hnizdo E, Barber C, Sumner J, Barraclough R, Bolton C, Burge S, Calverley P, Hopkinson N, Hoyle J, Lawson R, Niven R, Pickering T, Prowse K, Reid P, Warburton C, Blanc PD.

COPD. 2013 Apr;10(2):172-9. doi: 10.3109/15412555.2012.737072.

PMID:
23547628
11.

Asthma and occupation in the 1958 birth cohort.

Ghosh RE, Cullinan P, Fishwick D, Hoyle J, Warburton CJ, Strachan DP, Butland BK, Jarvis D.

Thorax. 2013 Apr;68(4):365-71. doi: 10.1136/thoraxjnl-2012-202151. Epub 2013 Jan 21.

PMID:
23339164
12.

DNA methylation biomarkers offer improved diagnostic efficiency in lung cancer.

Nikolaidis G, Raji OY, Markopoulou S, Gosney JR, Bryan J, Warburton C, Walshaw M, Sheard J, Field JK, Liloglou T.

Cancer Res. 2012 Nov 15;72(22):5692-701. doi: 10.1158/0008-5472.CAN-12-2309. Epub 2012 Sep 7.

13.

Correlation between perceived asthma control and thoraco-abdominal asynchrony in primary care patients diagnosed with asthma.

Upton J, Brodie D, Beales D, Richardson J, Jack S, Warburton C, Thomas M, Kendrick A.

J Asthma. 2012 Oct;49(8):822-9. doi: 10.3109/02770903.2012.717658. Epub 2012 Sep 10.

PMID:
22957811
14.

Standards of care for occupational asthma: an update.

Fishwick D, Barber CM, Bradshaw LM, Ayres JG, Barraclough R, Burge S, Corne JM, Cullinan P, Frank TL, Hendrick D, Hoyle J, Curran AD, Niven R, Pickering T, Reid P, Robertson A, Stenton C, Warburton CJ, Nicholson PJ.

Thorax. 2012 Mar;67(3):278-80. doi: 10.1136/thoraxjnl-2011-200755. Epub 2011 Dec 9.

PMID:
22156958
15.

Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspirates.

Dietrich D, Kneip C, Raji O, Liloglou T, Seegebarth A, Schlegel T, Flemming N, Rausch S, Distler J, Fleischhacker M, Schmidt B, Giles T, Walshaw M, Warburton C, Liebenberg V, Field JK.

Int J Oncol. 2012 Mar;40(3):825-32. doi: 10.3892/ijo.2011.1264. Epub 2011 Nov 16.

PMID:
22108652
16.

Chronic airflow limitation in a rural Indian population: etiology and relationship to body mass index.

Chakrabarti B, Purkait S, Gun P, Moore VC, Choudhuri S, Zaman MJ, Warburton CJ, Calverley PM, Mukherjee R.

Int J Chron Obstruct Pulmon Dis. 2011;6:543-9. doi: 10.2147/COPD.S24113. Epub 2011 Oct 18.

17.
18.

Guidelines on the radical management of patients with lung cancer.

Lim E, Baldwin D, Beckles M, Duffy J, Entwisle J, Faivre-Finn C, Kerr K, Macfie A, McGuigan J, Padley S, Popat S, Screaton N, Snee M, Waller D, Warburton C, Win T; British Thoracic Society; Society for Cardiothoracic Surgery in Great Britain and Ireland.

Thorax. 2010 Oct;65 Suppl 3:iii1-27. doi: 10.1136/thx.2010.145938.

PMID:
20940263
19.

Comparison of various airflow measurements in symptomatic textile workers.

Fishwick D, Barraclough R, Pickering T, Fletcher A, Lewis R, Niven R, Warburton CJ.

Occup Med (Lond). 2010 Dec;60(8):631-4. doi: 10.1093/occmed/kqq135. Epub 2010 Sep 15.

PMID:
20844055
20.

Cardiopulmonary exercise testing for the selection of patients undergoing surgery for lung cancer: friend or foe?

Lim E, Beckles M, Warburton C, Baldwin D.

Thorax. 2010 Oct;65(10):847-9. doi: 10.1136/thx.2009.133181. Epub 2010 Jul 13. No abstract available.

PMID:
20627906
21.

A study of patient attitudes in the United Kingdom toward ventilatory support in chronic obstructive pulmonary disease.

Chakrabarti B, Sulaiman MI, Davies L, Calverley PM, Warburton CJ, Angus RM.

J Palliat Med. 2009 Nov;12(11):1029-35. doi: 10.1089/jpm.2009.0160.

PMID:
19663712
22.
23.

Endobronchial carcinoid: an unusual cause of wheezing and chest pain.

Ganeshan D, Curtis J, Warburton C.

Br J Hosp Med (Lond). 2008 Nov;69(11):655. No abstract available.

PMID:
19069278
24.

Risk assessment of pneumothorax and pulmonary haemorrhage complicating percutaneous co-axial cutting needle lung biopsy.

Chakrabarti B, Earis JE, Pandey R, Jones Y, Slaven K, Amin S, McCann C, Jones PL, Thwaite E, Curtis JM, Warburton CJ.

Respir Med. 2009 Mar;103(3):449-55. doi: 10.1016/j.rmed.2008.09.010. Epub 2008 Oct 31.

25.

Treatment with a cholesterol absorption inhibitor (FM-VP4) reduces body mass and adipose accumulation in developing and pre-obese mice.

Thornton SJ, Warburton C, Wasan KM, Kozlowski P.

Drug Dev Ind Pharm. 2007 Oct;33(10):1058-69.

PMID:
17963113
26.

Are we failing workers with symptoms suggestive of occupational asthma?

Fishwick D, Bradshaw L, Davies J, Henson M, Stenton C, Burge S, Niven R, Warburton CJ, Hendrick D, Rogers T, Rawbone R, Curran AD.

Prim Care Respir J. 2007 Oct;16(5):304-10.

27.

Standards of care for occupational asthma.

Fishwick D, Barber CM, Bradshaw LM, Harris-Roberts J, Francis M, Naylor S, Ayres J, Burge PS, Corne JM, Cullinan P, Frank TL, Hendrick D, Hoyle J, Jaakkola M, Newman-Taylor A, Nicholson P, Niven R, Pickering A, Rawbone R, Stenton C, Warburton CJ, Curran AD; British Thoracic Society Standards of Care Subcommittee Guidelines on Occupational Asthma.

Thorax. 2008 Mar;63(3):240-50. Epub 2007 Sep 28. Review. No abstract available.

28.

Leishmania major abrogates gamma interferon-induced gene expression in human macrophages from a global perspective.

Dogra N, Warburton C, McMaster WR.

Infect Immun. 2007 Jul;75(7):3506-15. Epub 2007 Apr 30.

29.

Decreased levels of hypoxic cells in gefitinib treated ER+ HER-2 overexpressing MCF-7 breast cancer tumors are associated with hyperactivation of the mTOR pathway: therapeutic implications for combination therapy with rapamycin.

Dragowska WH, Verreault M, Yapp DT, Warburton C, Edwards L, Ramsay EC, Huxham LA, Minchinton AI, Gelmon K, Bally MB.

Breast Cancer Res Treat. 2007 Dec;106(3):319-31. Epub 2007 Mar 9.

PMID:
17347776
30.

Modulation of cancer cell survival pathways using multivalent liposomal therapeutic antibody constructs.

Chiu GN, Edwards LA, Kapanen AI, Malinen MM, Dragowska WH, Warburton C, Chikh GG, Fang KY, Tan S, Sy J, Tucker C, Waterhouse DN, Klasa R, Bally MB.

Mol Cancer Ther. 2007 Mar;6(3):844-55. Epub 2007 Mar 5.

31.

Occupational asthma: an assessment of diagnostic agreement between physicians.

Fishwick D, Bradshaw L, Henson M, Stenton C, Hendrick D, Burge S, Niven R, Warburton C, Rogers T, Rawbone R, Cullinan P, Barber C, Pickering T, Williams N, Ayres J, Curran AD.

Occup Environ Med. 2007 Mar;64(3):185-90. Epub 2006 Nov 9.

32.

Can you diagnose hyperventilation?

Warburton CJ, Jack S.

Chron Respir Dis. 2006;3(3):113-5. No abstract available.

PMID:
16916004
33.

Effect of primary-care spirometry on the diagnosis and management of COPD.

Walker PP, Mitchell P, Diamantea F, Warburton CJ, Davies L.

Eur Respir J. 2006 Nov;28(5):945-52. Epub 2006 Jul 26.

34.

The role of Abrams percutaneous pleural biopsy in the investigation of exudative pleural effusions.

Chakrabarti B, Ryland I, Sheard J, Warburton CJ, Earis JE.

Chest. 2006 Jun;129(6):1549-55.

PMID:
16778273
35.

Breathing patterns associated with trait anxiety and breathlessness in humans.

Masaoka Y, Jack S, Warburton CJ, Homma I.

Jpn J Physiol. 2004 Oct;54(5):465-70.

PMID:
15667670
36.

Development of a recombinant Leishmania major strain sensitive to ganciclovir and 5-fluorocytosine for use as a live vaccine challenge in clinical trials.

Davoudi N, Tate CA, Warburton C, Murray A, Mahboudi F, McMaster WR.

Vaccine. 2005 Jan 19;23(9):1170-7.

PMID:
15629360
37.

HER-2/neu overexpression increases the viable hypoxic cell population within solid tumors without causing changes in tumor vascularization.

Dragowska WH, Warburton C, Yapp DT, Minchinton AI, Hu Y, Waterhouse DN, Gelmon K, Skov K, Woo J, Masin D, Huxham LA, Kyle AH, Bally MB.

Mol Cancer Res. 2004 Nov;2(11):606-19.

39.

Ventilatory responses to inhaled carbon dioxide, hypoxia, and exercise in idiopathic hyperventilation.

Jack S, Rossiter HB, Pearson MG, Ward SA, Warburton CJ, Whipp BJ.

Am J Respir Crit Care Med. 2004 Jul 15;170(2):118-25. Epub 2004 Apr 1.

PMID:
15059786
40.

Behavioral influences and physiological indices of ventilatory control in subjects with idiopathic hyperventilation.

Jack S, Rossiter HB, Warburton CJ, Whipp BJ.

Behav Modif. 2003 Oct;27(5):637-52.

PMID:
14531159
41.

A physiological and psychological model of idiopathic hyperventilation.

Jack S, Warburton CJ.

Adv Exp Med Biol. 2001;499:439-44. No abstract available.

PMID:
11729922
42.

Surgery vs non-surgical treatment for bronchiectasis.

Corless JA, Warburton CJ.

Cochrane Database Syst Rev. 2000;(4):CD002180. Review.

PMID:
11034745
43.

Leukotriene receptor antagonists for non-cystic fibrosis bronchiectasis.

Corless JA, Warburton CJ.

Cochrane Database Syst Rev. 2000;(4):CD002174. Review.

PMID:
11034744
44.

Environmental exposure to air pollution and allergens and peak flow changes.

Higgins BG, Francis HC, Yates C, Warburton CJ, Fletcher AM, Pickering CA, Woodcock AA.

Eur Respir J. 2000 Jul;16(1):61-6.

45.

A comparison of performance of two personal sampling heads for cotton dust.

Niven RM, Fletcher AM, Pickering CA, Fishwick D, Francis HC, Warburton CJ, Oldham LA.

Ann Occup Hyg. 1998 May;42(4):253-8.

PMID:
9713248
46.
47.

Chronic bronchitis in textile workers.

Niven RM, Fletcher AM, Pickering CA, Fishwick D, Warburton CJ, Simpson JC, Francis H, Oldham LA.

Thorax. 1997 Jan;52(1):22-7.

48.

Functional upper airways obstruction: two patients with persistent symptoms.

Warburton CJ, McL Niven R, Higgins BG, Pickering CA.

Thorax. 1996 Sep;51(9):965-66.

49.

Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48.

Hirano K, Young SG, Farese RV Jr, Ng J, Sande E, Warburton C, Powell-Braxton LM, Davidson NO.

J Biol Chem. 1996 Apr 26;271(17):9887-90.

50.

Effects of air pollution on symptoms and peak expiratory flow measurements in subjects with obstructive airways disease.

Higgins BG, Francis HC, Yates CJ, Warburton CJ, Fletcher AM, Reid JA, Pickering CA, Woodcock AA.

Thorax. 1995 Feb;50(2):149-55.

Supplemental Content

Loading ...
Support Center